Anti-fap/interleukin-2 Fusion Protein Ro6874281

Anti-fap/interleukin-2 Fusion Protein Ro6874281 Uses, Dosage, Side Effects, Food Interaction and all others data.

Anti-fap/interleukin-2 Fusion Protein Ro6874281 is under investigation in clinical trial NCT03193190 (A Study of Multiple Immunotherapy-based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-pancreatic Cancer)).

Trade Name Anti-fap/interleukin-2 Fusion Protein Ro6874281
Generic RO6874281
RO6874281 Other Names Anti-fap/interleukin-2 fusion protein ro6874281, Simlukafusp alfa
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Anti-fap/interleukin-2 Fusion Protein Ro6874281
Anti-fap/interleukin-2 Fusion Protein Ro6874281

Innovators Monograph

You find simplified version here Anti-fap/interleukin-2 Fusion Protein Ro6874281


*** Taking medicines without doctor's advice can cause long-term problems.
Share